Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Craniopharyngioma × dabrafenib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 30 Thyroid Neoplasms 8 Thyroid Carcinoma, Anaplastic 7 Neoplasms 7 Neoplasm Metastasis 4 Multiple Myeloma 4 Ameloblastoma 4 Thyroid Cancer, Papillary 3 Hematologic Neoplasms 3 Colorectal Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Brain Neoplasms 3 Skin Neoplasms 2 Lymphoma, Non-Hodgkin 2 Glioma 2 Unspecified Adult Solid Tumor, Protocol Specific 1 Thyroid cancer, follicular 1 Thyroid cancer, Hurthle cell 1 Thrombocytosis 1 Solid Tumor 1 Sexual Dysfunction, Physiological 1 Rare Malignant Neoplasm 1 Prostatic Neoplasms 1 Primary Myelofibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasms by Site 1 Neoplasms by Histologic Type 1 Myeloproliferative Disorders 1

Interventions

Surgical Procedures, Operative 3 Exenatide 3 tocilizumab 2 Surveys and Questionnaires 2 Mental Status and Dementia Tests 2 Magnetic Resonance Spectroscopy 2 Donepezil 2 trametinib 1 tozuleristide 1 tovorafenib 1 temsirolimus 1 gallium Ga 68 dotatate 1 dabrafenib 1 cobimetinib 1 binimetinib 1 antineoplaston AS 2-1 1 antineoplaston A10 1 anlotinib 1 Vemurafenib 1 Tumor Burden 1 Transurethral Resection of Bladder 1 Thalidomide 1 Temozolomide 1 Radiotherapy, Image-Guided 1 Radiotherapy 1 Radiation 1 Qsymia 1 Proton Therapy 1 Photochemotherapy 1 Phentermine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05525273 2024-02-14

Swecranio

Skane University Hospital

Phase 2 Recruiting

Craniopharyngioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡